Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
American Eagle Outfitters
AEO
$3.05B
| $6.58M | ﹤0.01% |
265,250
+73,395
| +38% | +$1.86M |
|
|
CLR
1552
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $6.55M | ﹤0.01% |
96,000
+42,700
| +80% | +$2.7M |
|
1553
Ingevity
NGVT
$2.62B
| $6.54M | ﹤0.01% |
64,215
+46,424
| +261% | +$4.48M |
|
1554
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $6.53M | ﹤0.01% |
+150,888
| New | +$6.5M |
|
1555
PUT
Autodesk
ADSK
$54.2B
| $6.53M | ﹤0.01% |
41,800
+4,700
| +13% | +$664K |
|
1556
PUT
Harley-Davidson
HOG
$2.69B
| $6.52M | ﹤0.01% |
143,900
-279,000
| -66% | -$12.1M |
|
1557
CALL
Neurocrine Biosciences
NBIX
$16.8B
| $6.5M | ﹤0.01% |
52,900
+4,200
| +9% | +$477K |
|
1558
Tenet Healthcare
THC
$21B
| $6.5M | ﹤0.01% |
228,514
+32,129
| +16% | +$1.06M |
|
1559
PUT
RH
RH
$3.57B
| $6.5M | ﹤0.01% |
49,600
+2,000
| +4% | +$281K |
|
|
BBBY
1560
DELISTED
Bed Bath & Beyond Inc
BBBY
| $6.5M | ﹤0.01% |
433,073
+198,228
| +84% | +$3.71M |
|
|
VNE
1561
DELISTED
Veoneer, Inc.
VNE
| $6.48M | ﹤0.01% |
+117,749
| New | +$6.05M |
|
|
BPY
1562
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $6.46M | ﹤0.01% |
309,137
+308,446
| +44,638% | +$6.16M |
|
|
BZUN
1563
PUT
Baozun
BZUN
$171M
| $6.46M | ﹤0.01% |
132,900
-18,800
| -12% | -$1.02M |
|
|
AMED
1564
DELISTED
Amedisys
AMED
| $6.44M | ﹤0.01% |
51,536
+27,015
| +110% | +$2.98M |
|
1565
CALL
Xerox
XRX
$424M
| $6.42M | ﹤0.01% |
238,050
-11,350
| -5% | -$300K |
|
|
SHLX
1566
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $6.41M | ﹤0.01% |
299,857
-289,514
| -49% | -$6.53M |
|
|
COL
1567
CALL
DELISTED
Rockwell Collins
COL
| $6.41M | ﹤0.01% |
45,600
+28,100
| +161% | +$3.87M |
|
1568
Cimpress
CMPR
$2.29B
| $6.4M | ﹤0.01% |
46,870
+19,732
| +73% | +$2.85M |
|
1569
CALL
iShares US Real Estate ETF
IYR
$4.5B
| $6.4M | ﹤0.01% |
80,000
-36,700
| -31% | -$2.99M |
|
|
SHPG
1570
CALL
DELISTED
Shire pic
SHPG
| $6.4M | ﹤0.01% |
35,300
-55,700
| -61% | -$9.64M |
|
1571
CALL
Campbell Soup
CPB
$6.73B
| $6.39M | ﹤0.01% |
174,500
-289,500
| -62% | -$11.8M |
|
|
CADE
1572
DELISTED
Cadence Bank
CADE
| $6.39M | ﹤0.01% |
195,407
+78,207
| +67% | +$2.66M |
|
|
ICPT
1573
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.38M | ﹤0.01% |
50,517
+26,901
| +114% | +$2.85M |
|
|
PPLI
1574
CALL
People Inc
PPLI
$3.02B
| $6.37M | ﹤0.01% |
164,505
-79,455
| -33% | -$2.58M |
|
1575
CALL
Lumen
LUMN
$6.82B
| $6.37M | ﹤0.01% |
300,394
-169,900
| -36% | -$3.55M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.